Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition
暂无分享,去创建一个
[1] R. Stratta,et al. C‐peptide levels do not correlate with pancreas allograft failure: Multicenter retrospective analysis and discussion of the new OPT definition of pancreas allograft failure , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] M. Rickels,et al. Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop , 2018, Transplant international : official journal of the European Society for Organ Transplantation.
[3] A. Israni,et al. OPTN/SRTR 2016 Annual Data Report: Pancreas , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] Roy W Beck,et al. The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading , 2017, Diabetes Care.
[5] Howard C. Zisser,et al. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.
[6] M. Rickels,et al. Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes. , 2015, Diabetes technology & therapeutics.
[7] A. Israni,et al. OPTN/SRTR 2012 Annual Data Report: Pancreas , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] Y. Becker,et al. Long‐Term Pancreatic Allograft Survival After Renal Retransplantation in Prior Simultaneous Pancreas–Kidney Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] P. Choudhary,et al. Evaluating rate of change as an index of glycemic variability, using continuous glucose monitoring data. , 2011, Diabetes technology & therapeutics.
[10] A. Shapiro,et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. , 2004, Diabetes.